The newly added examples involve domestic and international programs for combating environmental deterioration, promoting the arts, providing relief to the poor, educating poor farmers in a developing county, supporting commercial employers in disaster areas, providing microloans to poor individuals in developing countries, constructing a child care facility in a low-income neighborhood, and furthering “orphan drug” research and development (e.g., finding a vaccine to prevent a disease that predominantly affects the poor in developing countries).
Two big foundations joined with a major force in impact investing today to create a pool of funds — potentially totaling $100 million — to support child care, affordable housing, job training, and other social priorities in Chicago.
“Any company we invest in needs to have the capabilities of touching the lives of 100,000 families within five years. These numbers are not hard to achieve in new economy businesses which are driven by tech-enabled platforms,”
In the case of generic drug repurposing research, the return on investment could come from some of the healthcare savings that the repurposed drug’s use would generate. In fact, it is likely that such healthcare savings would be greater than the amount needed to repay SIB investors, meaning that the amount of money saved by citizens and governments also would be significant. These financial benefits and improved health outcomes, in turn, could encourage governments, which usually do not fund generic drug repurposing trials, to support more such research.
A website for charities & social enterprises
Big Society Capital has produced its first comprehensive estimate of the size and composition of social investment in the UK.